Kangbo Knife
康博刀
Kangbo Knife (康博刀) is a composite cryo-ablation system developed by Haijieya Medical (海杰亚医疗), a Beijing-based company focused on minimally invasive tumor interventional therapy . The system is billed as the world's first to integrate deep-low-temperature freezing (-196°C) with high-intensity thermal ablation (+85°C) in a single platform, creating a near-300°C thermal differential to destroy solid tumors . It received China's NMPA innovation-track review, broke import dependence in the domestic market, was added to national medical insurance in 2021, and in April 2024 became the first Chinese tumor interventional system to secure FDA "Breakthrough Device" designation . Haijieya, founded in 2010, has since expanded its portfolio to include microwave ablation and AI surgical planning systems, with Kangbo Knife remaining its lead product .
AI-generated — may contain errors, please verify.
Coverage
Gaorong Ventures in Conversation with Hejeya and Qitan Tech: How Innovative Medical Devices "Cross the Razor's Edge"
"When you meet a mountain, you cut a path through it; when you meet a river, you build a bridge across it."
Haijieya Completes New Funding Round to Build Integrated Platform for Interventional Oncology Treatment
Providing a comprehensive suite of minimally invasive interventional diagnosis and treatment solutions for oncology.
Hygea Medical Completes Series C+ Round, Expanding Multi-Pipeline Portfolio in Minimally Invasive Tumor Interventional Therapy
Led by technologies such as the Cryoablation System, a new generation of minimally invasive tumor treatments is driving oncology toward procedures that are less invasive, more precise, and increasingly intelligent.
